PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
16307889-1	2006	The nitric oxide-releasing derivative of flurbiprofen, NCX 2216, has a safer gastrointestinal profile than the parent drug flurbiprofen and a strong anti-amyloidogenic activity.	Flurbiprofen	41-53	T cell leukemia homeobox 2	Homo sapiens	55-58	
16307889-1	2006	The nitric oxide-releasing derivative of flurbiprofen, NCX 2216, has a safer gastrointestinal profile than the parent drug flurbiprofen and a strong anti-amyloidogenic activity.	Flurbiprofen	123-135	T cell leukemia homeobox 2	Homo sapiens	55-58	
15850679-9	2005	Studies in cell lines and animal models have shown that flurbiprofen racemate, its R-enantiomer and its nitric oxide (NO)-releasing derivatives, HCT 1026 and NCX 2216, are effective on AD amyloid pathology.	Flurbiprofen	56-68	T cell leukemia homeobox 2	Homo sapiens	158-161